Titan Biotech Ltd — Board Meeting, 11-11-2025: Board Meeting
11-11-2025 | 03:51 pm
11-11-2025 | 03:51 pm
Titan Biotech's board approved the financial results for the quarter and half-year ended Sep 30. Consolidated Q2 Net Profit was 7.76 Cr, with H1 Net Profit at 14.63 Cr. Consolidated Q2 Revenue stood at 55.68 Cr, while H1 Revenue reached 102.90 Cr.
No comments yet. Be the first to comment!
